The potential role of insulin-like growth factor 1 in acne vulgaris and its correlation with the clinical response before and after treatment with metformin
- PMID: 35780292
- DOI: 10.1111/jocd.15210
The potential role of insulin-like growth factor 1 in acne vulgaris and its correlation with the clinical response before and after treatment with metformin
Abstract
Background: Acne vulgaris (AV) is a complex and multifactorial inflammatory disease affecting the pilosebaceous follicles. Optimum treatment of AV is important to reduce the disease severity and recurrence.
Aim: To evaluate the role of metformin in the treatment of acne vulgaris by reducing the level of insulin-like growth factor 1.
Methods: Fifty patients with AV were included in the study. Their ages ranged from 16 to 30 years, and they had different grades of the disease. IGF-1 levels were measured in all patients before and after the treatment with metformin.
Results: After 4 months of therapy, there was a clinical improvement detected by an improvement in the global acne grading system (GAGS) score and also a significant decrease in IGF-level.
Conclusion: IGF-1 may have an important role in the pathogenesis of acne; also we can presume that oral metformin is an effective and safe line in the treatment of AV.
Keywords: acne vulgaris; insulin-like growth factor 1; metformin.
© 2022 Wiley Periodicals LLC.
References
REFERENCES
-
- Tan JK. Psychosocial impact of acne vulgaris: evaluating the evidence. Skin Therapy Lett. 2012;9(7):1-3.
-
- Thiboutot D. Acne: hormonal concepts and therapy. Clin Dermatol. 2010;22(5):419-428.
-
- Damby FW. Acne and diet. Ann Dermatol Venereol. 2008;135:9-11.
-
- Mahmood SN, Bowe WP. Diet and acne update: carbohydrates emerge as the main culprit. J Drugs Dermatol. 2014;13(4):428-435.
-
- Bhate K, Williams HC. What's new in acne? an analysis of systematic reviews published in 2011-2012. Clin Exp Dermatol. 2014;39(3):273-277.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous